Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Science (New York, N.Y.)
|
December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Molecular Diagnostics : JMD
|
October 19, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study
Alexandra Saint-Charles, Julien Masliah-Planchon, Elnaz Saberi-Ansari, et al.
The Journal of Clinical Investigation
|
February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma
Lisa Werr, Jana Boland, Josephine Petersen, et al.
Pediatric Blood & Cancer
|
June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum
Steven G DuBois, Lucas Moreno, John Anderson, et al.
Cancer Discovery
|
April 4, 2024
The Virtual Child
Richard J Gilbertson, Sam Behjati, Anna-Lisa Böttcher, et al.
Nature
|
October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer, Falk Hertwig, Frederik Roels, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
Barbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.
Blood Cancer Discovery
|
March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7q
Etienne Sollier, Anna Riedel, Umut H Toprak, et al.
Cancer Discovery
|
August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
Cornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Nature
|
March 1, 2018
The landscape of genomic alterations across childhood cancers
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Science (New York, N.Y.)
|
December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Molecular Diagnostics : JMD
|
October 19, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study
Alexandra Saint-Charles, Julien Masliah-Planchon, Elnaz Saberi-Ansari, et al.
The Journal of Clinical Investigation
|
February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma
Lisa Werr, Jana Boland, Josephine Petersen, et al.
Pediatric Blood & Cancer
|
June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum
Steven G DuBois, Lucas Moreno, John Anderson, et al.
Cancer Discovery
|
April 4, 2024
The Virtual Child
Richard J Gilbertson, Sam Behjati, Anna-Lisa Böttcher, et al.
Nature
|
October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer, Falk Hertwig, Frederik Roels, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
Barbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.
Blood Cancer Discovery
|
March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7q
Etienne Sollier, Anna Riedel, Umut H Toprak, et al.
Cancer Discovery
|
August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
Cornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Nature
|
March 1, 2018
The landscape of genomic alterations across childhood cancers
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Page
of 14